Medical News
New drug combination offers hope to patients with currently untreatable Hepatitis C
Medical News Today - 5 Nov 2013 18:00
A novel single-pill combination drug could present a new treatment option for patients with the most difficult-to-treat forms of hepatitis C, according to the results of a Phase 2 trial, published in The Lancet. Hepatiti...
We must regulate e-cigarettes and electronic nicotine delivery systems says International Union Against Tuberculosis and Lung Disease
Medical News Today - 5 Nov 2013 12:00
At the 44th Union World Conference on Lung Health in Paris, members of the International Union Against Tuberculosis and Lung Health (The Union) issued a warning about the potential health impact of e-cigarettes and elect...
Domestic Violence Travels Down Through Generations, Study Finds
MedicineNet - 5 Nov 2013 09:00
Title: Domestic Violence Travels Down Through Generations, Study FindsCategory: Health NewsCreated: 11/1/2013 12:35:00 PMLast Editorial Review: 11/4/2013 12:00:00 AM
Drug combination therapy causes cancer cells to 'eat themselves'
e! Science News - 5 Nov 2013 20:36
Results from a recent preclinical study have shown that a new drug combination therapy being developed at Virginia Commonwealth University Massey Cancer Center effectively killed colon, liver, lung, kidney, breast and br...
Flying the Coop: Antibiotic Resistance Spreads to Birds, Other Wildlife
Scientific American - 5 Nov 2013 19:40
WORCESTER, Mass. – One afternoon last winter, Julie Ellis unfurled a long, white tarp under a stand of trees near Coes Pond where hundreds of crows roost. Her mission: to collect as much bird... --
Children Face Asthma Risk if Mothers Exposed to Pollutants
Scientific American - 5 Nov 2013 19:20
Children exposed in the womb to two chlorinated chemicals widely found in the environment are more likely to develop asthma by the age of 20, according to new research in Denmark. [More] --
Five questions that (should) keep chemists awake at night
Scientific American - 5 Nov 2013 18:18
The origin of life is chemistry's quintessential Big Question (Image: NASA) It is often said that chemistry lacks “big questions” like physics and biology. But this is not entirely... --
Pesticide exposure linked to increased endometriosis risk
Medical News Today - 5 Nov 2013 18:00
Endometriosis is a common condition that affects around 10% of women in their reproductive years. New research has found that two organochlorine pesticides - once widely used in the US for pest control and agriculture bu...
Implantable sensor may monitor cancer and diabetes
Medical News Today - 5 Nov 2013 18:00
New research details how a sensor that can be implanted under the skin for over 1 year is able to monitor inflammation and detect nitric oxide - a molecule that has been found to show disturbed levels in the presence of ...
The Hungary Life Sciences and Healthcare Conference, 22nd January 2014, Budapest
Medical News Today - 5 Nov 2013 18:00
The Hungary Life Sciences and Healthcare Conference is set to take place in Budapest on 22nd January 2014. As a reliable business hub in the very heart of Europe, Hungary's life sciences and medical technology industry i...
How Cancers Grow [Video]
Scientific American - 5 Nov 2013 16:15
A little more than a dozen years ago two researchers came up with a way of thinking about how tumors grow that changed the way most of the scientific community considered the hundred or more... --
New strep throat risk score brings patient data and big data together to potentially reduce unnecess
e! Science News - 5 Nov 2013 16:04
A new risk measure called a "home score" could save a patient with symptoms of strep throat a trip to the doctor, according to a new paper in the Annals of Internal Medicine, conducted by Andrew Fine, MD, MPH, and Kennet...
How the Brain Gets Addicted to Gambling
Scientific American - 5 Nov 2013 15:00
When Shirley was in her mid-20s she and some friends road-tripped to Las Vegas on a lark. That was the first time she gambled. Around a decade later, while working as an attorney on the East Coast,... --
Simple blood test may reveal spread of melanoma
Medical News Today - 5 Nov 2013 13:00
A simple blood test that examines chemical alterations in a gene called TFP12 may help identify patients whose melanoma has started to spread to other parts of the body. Researchers from the University of Dundee, UK, pre...
Early study shows that two targeted drugs with chemotherapy is safe and effective in advanced NSCLC
Medical News Today - 5 Nov 2013 12:00
A phase II study is the first to show that adding two targeted therapy drugs to the standard chemotherapy regimen is safe and effective as first-line treatment of advanced non-small-cell lung cancer (NSCLC). The research...
BioFreedom continues to demonstrate comparable long-term safety and efficacy to conventional DES
Medical News Today - 5 Nov 2013 12:00
Biosensors International has announced four- year results from the BioFreedom First in Man study (FIM), which demonstrated similar clinical outcomes between BioFreedomTM, a polymer-free drug-coated stent (DCS), and Bosto...
International trauma project set to reduce fatalities
Medical News Today - 5 Nov 2013 12:00
Several of the world's most renowned trauma teams, including Queen Mary University of London in partnership with The Royal London Hospital, are embarking on an extensive five-year project to investigate abnormal bleeding...
Clinicians rate patients with lung cancer with poorer quality of life
Medical News Today - 5 Nov 2013 12:00
Advances have been made in the treatment of lung cancer, but the disease continues to be a challenge to treat, primarily because of a high number of people who have late-stage cancer at the time of diagnosis, the likelih...
Simeprevir Phase 3 data announced at Annual Meeting of the American Association for the Study of Liver Diseases (AASLD)
Medical News Today - 5 Nov 2013 12:00
Janssen R&D Ireland (Janssen) has announced the presentation of new data at The Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) in Washington, DC for the investigational protease inhibi...
Phase 3 results announced for an all oral, sofosbuvir-based regimen for the treatment of hepatitis C in patients co-infected with HIV
Medical News Today - 5 Nov 2013 12:00
Gilead Sciences, Inc. (Nasdaq: GILD) has announced results from a Phase 3 study, PHOTON-1, evaluating the investigational once-daily nucleotide analogue inhibitor sofosbuvir for the treatment of chronic hepatitis C virus...
Phase 3 VALENCE study confirm efficacy and safety of all-oral sofosbuvir-based regimen in hepatitis C patients with genotype 3 infection
Medical News Today - 5 Nov 2013 12:00
Gilead Sciences, Inc. (Nasdaq: GILD) has announced results from two studies, the Phase 3 VALENCE study and the Phase 2 LONESTAR-2 study, evaluating the once-daily nucleotide analogue inhibitor sofosbuvir as part of combi...
FDA approves Roche's Gazyva (obinutuzumab) for people with previously untreated chronic lymphocytic leukemia (CLL)
Medical News Today - 5 Nov 2013 12:00
Roche (SIX: RO, ROG; OTCQX: RHHBY) has announced that the U.S. Food and Drug Administration (FDA) approved Gazyva (obinutuzumab), also known as GA101, in combination with chlorambucil chemotherapy for the treatment of pe...